Oncology Precision Medicine Market Size, Growth, and Strategic Insights 2026-2033 The oncology precision medicine industry is experiencing transformative growth driven by advancements in genomic profiling and targeted therapies. This sector is redefining cancer treatment paradigms through personalized approaches, substantially enhancing patient outcomes. The evolving landscape is marked by increased investment in precision diagnostics and biomarker-driven drug development, crucial for addressing heterogeneous tumor profiles. Market Size and Overview The Global Oncology Precision Medicine Market size is estimated to be valued at USD 153.81 billion in 2026 and is expected to reach USD 281.17 billion by 2033, exhibiting a compound annual growth rate (CAGR) of 9.0% from 2026 to 2033. Oncology Precision Medicine Market -https://www.coherentmi.com/industry-reports/oncology-precision-medicine-market